A new path forward for women living with period and pelvic pain

Uncovering the biology driving debilitating symptoms

A new path forward for women living with period and pelvic pain

July 1, 2026
Uncovering the biology driving debilitating symptoms
Read Transcript

The challenge

Pain associated with menstruation and conditions such as endometriosis is highly prevalent and can significantly affect quality of life, limiting participation in physical, educational and social activities. 

Among adolescents, up to 90% report experiencing period pain, and around 20% miss out on activities as a result. In adulthood, around 25% of women are reported to experience chronic pelvic pain – defined as pain lasting more than six months. 

While hormonal and other medications can provide relief for some, there remains a group of women whose pain is extremely difficult to manage. Researchers at Murdoch Children's Research Institute are seeking to better understand why.

The research

Researchers are investigating the role that inflammation may play in period and pelvic pain. By comparing inflammatory markers in women with and without pain across different stages of the menstrual cycle, the team hopes to identify the biological processes that drive period and pelvic pain. 

Importantly, this type of exploration has successfully led to novel treatments for pain associated with migraines and sickle cell disease – by identifying the inflammatory marker that is driving the pain and then repurposing known drugs for new indications.

The role of philanthropy

By supporting researchers to explore new approaches to understanding the biological drivers of period and pelvic pain, philanthropy is helping unlock the potential for more targeted treatment options for women whose symptoms remain difficult to manage.

What this could unlock

Hearts & Minds funding, as nominated by Munro Partners, has enabled this research to commence. If this research succeeds in identifying the inflammatory processes driving pain, clinicians may one day be able to identify women who could benefit from targeted treatments much earlier in their care.

The long-term goal is to offer women an alternative approach to managing period and pelvic pain, guided by a better understanding of the biological processes driving their symptoms.

Funding support from Hearts & Minds, as nominated by Core Fund Manager, Munro Partners. This content was last updated in July 2026. For further information, visit Murdoch Children's Research Institute.

The challenge

Pain associated with menstruation and conditions such as endometriosis is highly prevalent and can significantly affect quality of life, limiting participation in physical, educational and social activities. 

Among adolescents, up to 90% report experiencing period pain, and around 20% miss out on activities as a result. In adulthood, around 25% of women are reported to experience chronic pelvic pain – defined as pain lasting more than six months. 

While hormonal and other medications can provide relief for some, there remains a group of women whose pain is extremely difficult to manage. Researchers at Murdoch Children's Research Institute are seeking to better understand why.

The research

Researchers are investigating the role that inflammation may play in period and pelvic pain. By comparing inflammatory markers in women with and without pain across different stages of the menstrual cycle, the team hopes to identify the biological processes that drive period and pelvic pain. 

Importantly, this type of exploration has successfully led to novel treatments for pain associated with migraines and sickle cell disease – by identifying the inflammatory marker that is driving the pain and then repurposing known drugs for new indications.

The role of philanthropy

By supporting researchers to explore new approaches to understanding the biological drivers of period and pelvic pain, philanthropy is helping unlock the potential for more targeted treatment options for women whose symptoms remain difficult to manage.

What this could unlock

Hearts & Minds funding, as nominated by Munro Partners, has enabled this research to commence. If this research succeeds in identifying the inflammatory processes driving pain, clinicians may one day be able to identify women who could benefit from targeted treatments much earlier in their care.

The long-term goal is to offer women an alternative approach to managing period and pelvic pain, guided by a better understanding of the biological processes driving their symptoms.

Funding support from Hearts & Minds, as nominated by Core Fund Manager, Munro Partners. This content was last updated in July 2026. For further information, visit Murdoch Children's Research Institute.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.